Image by National Cancer Institute
ΚΛΙΝΙΚΕΣ ΜΕΛΕΤΕΣ

Prof. ΙΩΑΝΝΗΣ Κ. ΤΡΙΑΝΤΑΦΥΛΛΙΔΗΣ M.D., Ph.D., F.E.B.G.H., M.A.C.G. 
ASSOCIATE PROFESSOR, “GR. T. POPA” UNIVERSITY OF MEDICINE & PHARMACY, IASI, ROMANIA

ΚΛΙΝΙΚΕΣ ΜΕΛΕΤΕΣ

​Στο γαστρεντερολογικό Τμήμα του Κρατικού νοσοκομείου Νίκαιας διενεργήθηκαν πολλές διεθνείς πολυκεντρικές μελέτες. Κατωτέρω αναφέρονται ενδεικτικώς οι πλέον πρόσφατες μελέτες στις οποίες συμμετείχε ενεργώς το Τμήμα μας. 


1. STUDY C87055: Certolizumab Pegol in the treatment of adult Greek patients with moderate to severe Crohn’s disease, who have been previously treated successfully with infliximab but who have subsequently lost the response or have developed intolerance to infliximab: an open-label, multi-center single-cohort study to evaluate efficacy, safety and onset of action.


2. STUDY MeFi/04/OBR-IBS/001: Otilonium bromide in irritable bowel syndrome (OBIS). Double blind, randomized, parallel  group, placebo-controlled study to evaluate the effect of otilonium bromide on abdominal pain and quality of life in patients with irritable bowel syndrome. 


3. STUDY M06-829: A multi-center, open-label study of the fully human anti-TNF monoclonal antibody Adalinumab for the induction and maintenance of clinical remission in subjects with moderate to severe Crohn’s disease.